Patents by Inventor Patricia Martin

Patricia Martin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11021558
    Abstract: Provided are polymer compositions made by a process comprising: (a) providing a first reactive composition containing: (i) a polymerization initiator that is capable, upon a first activation, of forming two or more free radical groups, at least one of which is further activatable by subsequent activation; (ii) one or more ethylenically unsaturated compounds; and (iii) a crosslinker; (b) subjecting the first reactive composition to a first activation step such that the first reactive composition polymerizes therein to form a crosslinked substrate network containing a covalently bound activatable free radical initiator, (c) combining the crosslinked substrate network with a second reactive composition containing one or more ethylenically unsaturated compounds; and (d) activating the covalently bound activatable free radical initiator of the crosslinked substrate network such that the second reactive composition polymerizes therein with the crosslinked substrate network to form a grafted polymeric network and a
    Type: Grant
    Filed: July 21, 2017
    Date of Patent: June 1, 2021
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Brian Aitken, Charles Scales, Scott Joslin, Yong Zhang, Dola Sinha, Shivkumar Mahadevan, Patricia Martin, Fang Lu, Donnie Duis, Stephen C. Arnold
  • Patent number: 10975040
    Abstract: Described are high energy light blocking compounds and ophthalmic devices containing the compounds. In particular, described are hydroxyphenyl naphthotriazole structures with polymerizable functionality that block high energy light and are visibly transparent. The hydroxyphenyl naphthotriazole structures can be incorporated into ophthalmic devices, such as hydrogel contact lenses, to protect eyes from high energy light radiation.
    Type: Grant
    Filed: November 15, 2019
    Date of Patent: April 13, 2021
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Shivkumar Mahadevan, Leilani K. Sonoda, Dola Sinha, Patricia Martin
  • Patent number: 10961341
    Abstract: Provided are ophthalmic devices comprised of a reaction product of a composition comprising: (i) a crosslinked substrate network containing covalently bound activatable free radical initiators; and (ii) a grafting composition containing one or more ethylenically unsaturated compounds. Also provided are processes for making ophthalmic devices.
    Type: Grant
    Filed: January 4, 2019
    Date of Patent: March 30, 2021
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Brian Aitken, Charles Scales, Scott Joslin, Yong Zhang, Dola Sinha, Shivkumar Mahadevan, Patricia Martin, Fang Lu, Donnie Duis, Stephen C. Arnold
  • Publication number: 20210061934
    Abstract: Described are contact lenses that contain high energy visible (HEV) light absorbing compounds and their use for improving one or more vision attributes.
    Type: Application
    Filed: July 24, 2020
    Publication date: March 4, 2021
    Inventors: Patricia Martin, John R. Buch, Jessica Cannon, Shivkumar Mahadevan, Dawn D. Wright
  • Publication number: 20200315168
    Abstract: Fragrant and antimicrobial properties were conferred to cotton fabrics following microencapsulation using green materials. Limonene and vanillin microcapsules were produced by complex coacervation using chitosan/gum Arabic as shell materials and tannic acid as hardening agent. The effect of two emulsifiers; Span 85 and polyglycerol polyricinoleate (PGPR), on the encapsulation efficiency (EE %), microcapsule's size and morphology, and cumulative release profiles was studied. The use of Span 85 resulted in mononuclear morphology while PGPR gave rise to polynuclear structures, regardless of the core material (vanillin or limonene). The obtained microcapsules demonstrated a sustained release patter. Grafting of the produced microcapsules onto cotton fabrics through an esterification reaction using citric acid as anon-toxic cross-linker followed by thermofixation and curing, was confirmed by SEM and FTIR spectroscopy.
    Type: Application
    Filed: March 26, 2018
    Publication date: October 8, 2020
    Inventors: Asma Mohamad Abdallah Sharkawy, tamer Shoeib, Alirio Egidio Rodrigues, Maria Filomena Filipe Barreiro, Isabel Patrícia Martins Fernandes
  • Patent number: 10752720
    Abstract: Described are high energy light blocking compounds and ophthalmic devices containing the compounds. In particular, described are hydroxybiphenyl benzotriazole structures with polymerizable functionality that block high energy light and are visibly transparent. The hydroxybiphenyl benzotriazole structures can be incorporated into ophthalmic devices, such as hydrogel contact lenses, to protect eyes from high energy light radiation.
    Type: Grant
    Filed: May 15, 2018
    Date of Patent: August 25, 2020
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Shivkumar Mahadevan, Leilani K. Sonoda, Dola Sinha, Patricia Martin
  • Patent number: 10723732
    Abstract: Described are high energy light blocking compounds and ophthalmic devices containing the compounds. In particular, described are hydroxyphenyl phenanthroline structures with polymerizable functionality that block high energy light and are visibly transparent. The hydroxyphenyl phenanthroline structures can be incorporated into ophthalmic devices, such as hydrogel contact lenses, to protect eyes from high energy light radiation.
    Type: Grant
    Filed: May 15, 2018
    Date of Patent: July 28, 2020
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Shivkumar Mahadevan, Leilani K. Sonoda, Dola Sinha, Patricia Martin
  • Patent number: 10709776
    Abstract: The present invention relates to ex vivo method for producing outer membrane vesicles (OMVs) by expression or overexpression of the hemolysin F gene (hlyF) in gram-negative bacterium.
    Type: Grant
    Filed: April 7, 2015
    Date of Patent: July 14, 2020
    Assignees: INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT, UNIVERSITÉ PAUL SABATIER TOULOUSE III, CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE
    Inventors: Eric Oswald, Patricia Martin, Kazunori Murase
  • Publication number: 20200079743
    Abstract: Described are high energy light blocking compounds and ophthalmic devices containing the compounds. In particular, described are hydroxyphenyl naphthotriazole structures with polymerizable functionality that block high energy light and are visibly transparent. The hydroxyphenyl naphthotriazole structures can be incorporated into ophthalmic devices, such as hydrogel contact lenses, to protect eyes from high energy light radiation.
    Type: Application
    Filed: November 15, 2019
    Publication date: March 12, 2020
    Inventors: Shivkumar Mahadevan, Leilani K. Sonoda, Dola Sinha, Patricia Martin
  • Publication number: 20200048187
    Abstract: The invention is based on the discovery of a new bacterial compound with analgesic properties which could be used as a new tool for the treatment of pain disorders such as visceral pain. Studying the mechanisms implicated in analgesic properties of the probiotic Escherichia coli strain Nissle 1917 (EcN), inventors characterized, the amino fatty acids produced by EcN, which display the Ecn analgesic properties. One of these compounds inhibits the hypersensitivity to colorectal distension induced by capsaicin, which is a very powerful nociceptive compound and acts via the GABA B receptor. Furthermore, inventors demonstrate that this compound is able to cross the cellular epithelial barrier (such as the intestinal epithelium). Thus, the invention relates to a lipopetide compound, derived from gamma-aminobutyric acid. The invention also relates to a lipopeptide compound according to the invention for the treatment of treating pain disorder, such as somatic pain and visceral pain.
    Type: Application
    Filed: April 27, 2018
    Publication date: February 13, 2020
    Inventors: Nicolas CENAC, Justine BERTRAND-MICHEL, Teresa PEREZ-BEREZO, Thierry DURAND, Jean-Marie GALANO, Julien PUJO, Eric OSWALD, Patricia MARTIN, Pauline LE FAOUDER, Alexandre GUY
  • Patent number: 10526296
    Abstract: Described are high energy light blocking compounds and ophthalmic devices containing the compounds. In particular, described are hydroxyphenyl naphthotriazole structures with polymerizable functionality that block high energy light and are visibly transparent. The hydroxyphenyl naphthotriazole structures can be incorporated into ophthalmic devices, such as hydrogel contact lenses, to protect eyes from high energy light radiation.
    Type: Grant
    Filed: May 15, 2018
    Date of Patent: January 7, 2020
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Shivkumar Mahadevan, Leilani K. Sonoda, Dola Sinha, Patricia Martin
  • Publication number: 20200002267
    Abstract: Described are polymerizable high energy light absorbing compounds of formula I: Wherein Y, Pg, R1, R2, R3, R4, R5, and R6 are as described herein. The compounds absorb various wavelengths of ultraviolet and/or high energy visible light and are suitable for incorporation in various products, such as biomedical devices and ophthalmic devices.
    Type: Application
    Filed: April 30, 2019
    Publication date: January 2, 2020
    Inventors: Ghulam Maharvi, Shivkumar Mahadevan, Stephen C. Arnold, Patricia Martin, Leilani K. Sonoda, Dola Sinha
  • Publication number: 20190233572
    Abstract: Provided are ophthalmic devices comprised of a reaction product of a composition comprising: (i) a crosslinked substrate network containing covalently bound activatable free radical initiators; and (ii) a grafting composition containing one or more ethylenically unsaturated compounds. Also provided are processes for making ophthalmic devices.
    Type: Application
    Filed: January 4, 2019
    Publication date: August 1, 2019
    Inventors: Brian Aitken, Charles Scales, Scott Joslin, Yong Zhang, Dola Sinha, Shivkumar Mahadevan, Patricia Martin, Fang Lu, Donnie Duis, Stephen C. Arnold
  • Publication number: 20190002415
    Abstract: Described are high energy light blocking compounds and ophthalmic devices containing the compounds. In particular, described are hydroxyphenyl naphthotriazole structures with polymerizable functionality that block high energy light and are visibly transparent. The hydroxyphenyl naphthotriazole structures can be incorporated into ophthalmic devices, such as hydrogel contact lenses, to protect eyes from high energy light radiation.
    Type: Application
    Filed: May 15, 2018
    Publication date: January 3, 2019
    Inventors: Shivkumar Mahadevan, Leilani K. Sonoda, Dola Sinha, Patricia Martin
  • Publication number: 20190002459
    Abstract: Described are high energy light blocking compounds and ophthalmic devices containing the compounds. In particular, described are hydroxyphenyl phenanthroline structures with polymerizable functionality that block high energy light and are visibly transparent. The hydroxyphenyl phenanthroline structures can be incorporated into ophthalmic devices, such as hydrogel contact lenses, to protect eyes from high energy light radiation.
    Type: Application
    Filed: May 15, 2018
    Publication date: January 3, 2019
    Inventors: Shivkumar Mahadevan, Leilani K. Sonoda, Dola Sinha, Patricia Martin
  • Publication number: 20180371139
    Abstract: Described are high energy light blocking compounds and ophthalmic devices containing the compounds. In particular, described are hydroxybiphenyl benzotriazole structures with polymerizable functionality that block high energy light and are visibly transparent. The hydroxybiphenyl benzotriazole structures can be incorporated into ophthalmic devices, such as hydrogel contact lenses, to protect eyes from high energy light radiation.
    Type: Application
    Filed: May 15, 2018
    Publication date: December 27, 2018
    Inventors: Shivkumar Mahadevan, Leilani K. Sonoda, Dola Sinha, Patricia Martin
  • Publication number: 20180037690
    Abstract: Provided are polymer compositions made by a process comprising: (a) providing a first reactive composition containing: (i) a polymerization initiator that is capable, upon a first activation, of forming two or more free radical groups, at least one of which is further activatable by subsequent activation; (ii) one or more ethylenically unsaturated compounds; and (iii) a crosslinker; (b) subjecting the first reactive composition to a first activation step such that the first reactive composition polymerizes therein to form a crosslinked substrate network containing a covalently bound activatable free radical initiator, (c) combining the crosslinked substrate network with a second reactive composition containing one or more ethylenically unsaturated compounds; and (d) activating the covalently bound activatable free radical initiator of the crosslinked substrate network such that the second reactive composition polymerizes therein with the crosslinked substrate network to form a grafted polymeric network and a
    Type: Application
    Filed: July 21, 2017
    Publication date: February 8, 2018
    Inventors: Brian Aitken, Charles Scales, Scott Joslin, Yong Zhang, Dola Sinha, Shivkumar Mahadevan, Patricia Martin, Fang Lu, Donnie Duis, Stephen C. Arnold
  • Publication number: 20170112913
    Abstract: The present invention relates to ex vivo method for producing outer membrane vesicles (OMVs) by expression or overexpression of the hemolysin F gene (hlyF) in gram-negative bacterium.
    Type: Application
    Filed: April 7, 2014
    Publication date: April 27, 2017
    Inventors: Eric OSWALD, Patricia MARTIN, Kazunori MURASE
  • Publication number: 20120325881
    Abstract: The present invention is an interactive reversible apron and is used to amuse and entertain a baby with an assortment of interactive items and mobile media devices. The assortment of interactive items includes but is not limited to objects such as baby toys, a pacifier, and finger puppets. The mobile media devices can include objects such as a smart phone and a tablet personal computer. The assortment of interactive items and the mobile media devices held in place and support on the user's chest by the present invention. The user puts the present invention on, sits down, and places the baby on the lap so that the baby can access the assortment of interactive items and the mobile media devices. While the baby is sitting on the user's lap, the present invention prevents both the user and the baby from getting restless and allows the user to develop a personal connection with the baby.
    Type: Application
    Filed: June 22, 2011
    Publication date: December 27, 2012
    Inventor: Patricia Martin WHITE
  • Patent number: D695494
    Type: Grant
    Filed: May 26, 2011
    Date of Patent: December 17, 2013
    Inventor: Patricia Martin White